Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Ovarian low malignant potential tumor
Results 1-19 of 19 for your search:
Start Over
Intraperitoneal and/or Intravenous Carboplatin or Cisplatin and Paclitaxel in Treating Patients With Newly Diagnosed, Stage IIB-IV Epithelial Ovarian Cancer, Peritoneal Cavity, or Fallopian Tube Cancer
Phase: Phase III, Phase II
Type: Treatment
Age: 18 and over
Trial IDs: OV.21, NCI-2013-00331, 0902, CAN-NCIC-OV21, CDR0000655241, GEICO-0902, SWOG OV.21, UCL08/0379, NCIC CTG OV.21, NCT00993655
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: D0816C00002, NCI-2014-00976, NCT01874353
Pralatrexate and Carboplatin in Treating Patients with Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 10-113, NCI-2011-00045, NCT01188876
Vaccine Therapy in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC29810, NCI-2011-00285, NCT01312389
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Iodine I 124 NM404 in Patients with Advanced Solid Malignancies
Phase: Phase II, Phase I
Type: Diagnostic
Age: 18 and over
Trial IDs: CO12901, NCI-2012-01953, 2012-0230-CP009, NCT01662284
A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 21
Trial IDs: M18-005, NCI-2014-01397, NCT01952249
Phase IB/II Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 19 and over
Trial IDs: F140214007 (UAB 1357), NCI-2015-00264, 000505867, NCT02195973
Nintedanib in Treating Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Previously Treated with Bevacizumab
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: Pro00033060, NCI-2013-00455, NCT01669798
Surgery with or without Carboplatin in Treating Patients with Recurrent Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Phase: Phase II
Type: Treatment
Age: Over 21
Trial IDs: 12-275, NCI-2013-00405, NCT01767675
A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CO-338-017, NCI-2013-01733, NCT01891344
LY2606368 in Treating Patients with BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Non-high Risk Triple Negative Breast Cancer, or High Grade Ovarian Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0156, NCI-2014-02304, 140156, 342996, P131428, NCT02203513
Cabozantinib-S-Malate in Treating Patients with Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: NRG GY-001, NCI-2014-02411, NCT02315430
Veliparib, Paclitaxel, and Carboplatin in Treating Patients with Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 10-115, NCI-2011-02500, CDR0000700997, 8808, NCT01366144
A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) Deficiency
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 115717, NCI-2012-01219, NCT01458067
Dendritic Cell Vaccine With Auto Tumor Cells for Ovarian Peritoneal, Fallopian Tube, or Endometrial Cancer
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 19809, NCI-2010-01307, NCT01132014
Ketorolac After Surgery in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: INST 1115, NCI-2012-00917, NCT01670799
Start Over